The Evolution of Duplicated Genes of the Cpi-17/Phi-1 (<i>ppp1r14</i>) Family of Protein Phosphatase 1 Inhibitors in Teleosts

• Main Authors: Irene Lang, Guneet Virk, Dale C. Zheng, Jason Young, Michael J. Nguyen, Rojin Amiri, Michelle Fong, Alisa Arata, Katia S. Chadaideh, Susan Walsh, Douglas C. Weiser
• Format: Article
• Language: English
• Published: MDPI AG 2020-08-01
• Series: International Journal of Molecular Sciences
• Subjects: Danio rerio; Phi-1 (ppp1r14b); Cpi-17 (ppp1r14a); PP1; Mypt1; genome duplication
• Online Access: https://www.mdpi.com/1422-0067/21/16/5709
• ISSN: 1661-6596; 1422-0067

The Cpi-17 (<i>ppp1r14</i>) gene family is an evolutionarily conserved, vertebrate specific group of protein phosphatase 1 (PP1) inhibitors. When phosphorylated, Cpi-17 is a potent inhibitor of myosin phosphatase (MP), a holoenzyme complex of the regulatory subunit Mypt1 and the catalytic subunit PP1. Myosin phosphatase dephosphorylates the regulatory myosin light chain (Mlc2) and promotes actomyosin relaxation, which in turn, regulates numerous cellular processes including smooth muscle contraction, cytokinesis, cell motility, and tumor cell invasion. We analyzed zebrafish homologs of the Cpi-17 family, to better understand the mechanisms of myosin phosphatase regulation. We found single homologs of both Kepi (<i>ppp1r14c</i>) and Gbpi (<i>ppp1r14d</i>) in silico, but we detected no expression of these genes during early embryonic development. Cpi-17 (<i>ppp1r14a</i>) and Phi-1 (<i>ppp1r14b</i>) each had two duplicate paralogs, (<i>ppp1r14aa</i> and <i>ppp1r14ab</i>) and (<i>ppp1r14ba</i> and <i>ppp1r14bb</i>), which were each expressed during early development. The spatial expression pattern of these genes has diverged, with <i>ppp1r14aa</i> and <i>ppp1r14bb</i> expressed primarily in smooth muscle and skeletal muscle, respectively, while <i>ppp1r14ab</i> and <i>ppp1r14ba</i> are primarily expressed in neural tissue. We observed that, in in vitro and heterologous cellular systems, the Cpi-17 paralogs both acted as potent myosin phosphatase inhibitors, and were indistinguishable from one another. In contrast, the two Phi-1 paralogs displayed weak myosin phosphatase inhibitory activity in vitro, and did not alter myosin phosphorylation in cells. Through deletion and chimeric analysis, we identified that the difference in specificity for myosin phosphatase between Cpi-17 and Phi-1 was encoded by the highly conserved PHIN (phosphatase holoenzyme inhibitory) domain, and not the more divergent N- and C- termini. We also showed that either Cpi-17 paralog can rescue the knockdown phenotype, but neither Phi-1 paralog could do so. Thus, we provide new evidence about the biochemical and developmental distinctions of the zebrafish Cpi-17 protein family.